ADSTILADRIN IS FULLY AVAILABLE.

Header image of a man walking with a horse, plus ADSTILADRIN genie

Header image of a man walking with a horse, plus ADSTILADRIN genie

STIL DOING IT MY WAY With ADSTILADRIN

Meet Mike, an actual ADSTILADRIN patient, and watch his story.

What’s His Way?

Abbreviations: BCG, Bacillus Calmette-Guérin; NMIBC, non–muscle-invasive bladder cancer.

Header image of a man and children playing ball in the pool, plus ADSTILADRIN genie — Not an actual ADSTILADRIN patient.

Header image of a man and children playing ball in the pool, plus ADSTILADRIN genie — Not an actual ADSTILADRIN patient.

STIL DOING IT MY WAY With ADSTILADRIN

A unique treatment that
may help you keep your bladder

What’s your way?

Learn About ADSTILADRIN

Abbreviations: BCG, Bacillus Calmette-Guérin; NMIBC, non–muscle-invasive bladder cancer.

Header image of a couple holding hands and walking with suitcases, plus ADSTILADRIN genie — Not actual ADSTILADRIN patients.

Header image of a couple walking through a station — Not actual ADSTILADRIN patients.

STIL DOING IT MY WAY With ADSTILADRIN

A unique treatment that
may help you keep your bladder

What’s your way?

Learn About ADSTILADRIN

Abbreviations: BCG, Bacillus Calmette-Guérin; NMIBC, non–muscle-invasive bladder cancer.

Did your high-risk NMIBC stop responding to BCG treatment?
If so, ADSTILADRIN may be a treatment that fits your life

STIL effective
STIL manageable safety
STIL convenient

STIL able to KEEP YOUR BLADDER

Prescription bottle

More than half

of the people who took ADSTILADRIN (ad-still-uh-drin) in a clinical study had a complete response (with no signs of high-grade bladder cancer) after just 1 dose (n=50).

Nearly half

of people were estimated to keep their bladder.

Some people still had complete responses out to 5 years (n=6).

96^%(n=103/107)

OUT TO 5 YEARS
Of the people who received at least 1 dose of ADSTILADRIN, most did not progress to muscle-invasive bladder cancer, even if their cancer didn’t go away completely (based on results from a TURBT)

Explore Results

STIL HAS A MANAGEABLE SAFETY PROFILE
out to 5 years

Most side effects
were mild

and went away after a median of JUST 2 DAYS.*

11% of people had serious side effects
Only 3 people had to stop treatment due to side effects

No new side effects

were reported.

No deaths occurred

due to treatment-related side effects.

STIL CONVENIENT—
dosing just ONCE EVERY 3 MONTHS

Delivered directly into
the bladder

through a urinary catheter.

by your urologist

in their office.

Explore Treatment

STIL effective

STIL able to KEEP YOUR BLADDER

Prescription bottle

More than half

of the people who took ADSTILADRIN (ad-still-uh-drin) in a clinical study had a complete response (with no signs of high-grade bladder cancer) after just 1 dose (n=50).

Nearly half

of people were estimated to keep their bladder.

Some people still had complete responses out to 5 years (n=6).

96^%(n=103/107)

OUT TO 5 YEARS
Of the people who received at least 1 dose of ADSTILADRIN, most did not progress to muscle-invasive bladder cancer, even if their cancer didn’t go away completely (based on results from a TURBT)

Explore Results

STIL manageable safety

STIL HAS A MANAGEABLE SAFETY PROFILE
out to 5 years

Most side effects
were mild

and went away after a median of JUST 2 DAYS.*

11% of people had serious side effects
Only 3 people had to stop treatment due to side effects

No new side effects

were reported.

No deaths occurred

due to treatment-related side effects.

STIL convenient

STIL CONVENIENT—
dosing just ONCE EVERY 3 MONTHS

Delivered directly into
the bladder

through a urinary catheter.

by your urologist

in their office.

Explore Treatment

Recommended by
the experts

ADSTILADRIN is recommended by the National Comprehensive Cancer Network^®(NCCN),^† the American Urological Association (AUA), and the Society of Urologic Oncology (SUO)

ADSTILADRIN is a localized treatment.
It is NOT chemotherapy

It causes the immune system to fight cancer directly in the bladder. It does not spread throughout the body. This may reduce side effects

Learn More

What’s Mike’s Way?

“
He told me there are no tumors, and this gave me a tremendous feeling of hope and joy.
”

Mike, an actual patient diagnosed with NMIBC and treated with ADSTILADRIN (nadofaragene firadenovec-vncg)

Individual results may vary.

What’s Mike’s Way? video

*Except for fatigue and frequent daytime urination.

^†Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Bladder Cancer V.4.2024. © National Comprehensive Cancer Network, Inc. 2024. All rights reserved. Accessed June 1, 2024. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

NEXTWhat Is NMIBC?

Important Safety Information

INDICATION

ADSTILADRIN is a treatment for adults who have all the following:

High-risk non–muscle-invasive bladder cancer (NMIBC)
Cancer that is not responding to Bacillus Calmette-Guérin (BCG) therapy
Carcinoma in situ (CIS) with or without other high-grade tumors

IMPORTANT SAFETY INFORMATION

Who should not receive ADSTILADRIN?
Do not receive ADSTILADRIN if you have a sensitivity to interferon alfa or any of its components.

What is the most important information I should know about ADSTILADRIN?
Individuals who are immunosuppressed or immune-deficient should not prepare, administer, receive or come into contact with ADSTILADRIN.

What should I tell my healthcare provider?
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of ADSTILADRIN?
The most common side effects of ADSTILADRIN include:
Urinary discharge, fatigue, bladder spasm, urgency to urinate, and blood in your urine.

These are not all the possible side effects of ADSTILADRIN. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-332-10881-800-332-1088. You may also contact Ferring Pharmaceuticals at 1-888-FERRING1-888-FERRING.

What other information should I know about using ADSTILADRIN?
For 2 days following treatment, voided urine should be disinfected for 15 minutes with an equal volume of bleach before flushing.

For more important information, call 1-888-337-74641-888-337-7464.

Please see full Prescribing Information.

You are now leaving the ADSTILADRIN website.